Clinical Trial Update: IV Lidocaine in Pediatric AIS [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intravenous lidocaine in pediatric acute ischemic stroke was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Systemic Lidocaine Improves Pain Control After Surgery by Attenuating the Systemic Inflammatory Response to Surgery | Phase 4 | Status: TERMINATED | Results posted: 2025-11-12